Sientra Stock News

Here's what you need to know about buying penny stocks on August 8th The post Penny Stocks to Buy on August 8th? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

SANTA BARBARA, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the Virtual 19 th Annual Craig-Hallum In

Sientra, Inc. (NASDAQ:SIEN ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Oliver Bennett - Senior Vice President, General Counsel & Chief Compliance Officer Ron Meneze

Sientra (SIEN) delivered earnings and revenue surprises of -11.54% and 5.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SANTA BARBARA, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art

Penny stocks with unusual options volume in the stock market today. The post 3 Penny Stocks Investors Are Betting On Big For A Downfall appeared first on Penny Stocks to Buy, Picks, News and Informati

Maxim lowered the price target on Sientra Inc (NASDAQ: SIEN) to $7 from $13 but kept a Buy rating on the stock.  Analyst Anthony Vendetti notes that the Company's Q4 revenue was in-line with its p

Sientra (SIEN) delivered earnings and revenue surprises of -42.11% and 0.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Sientra, Inc. (SIEN) CEO Ron Menezes on Q4 2021 Results - Earnings Call Transcript

Sientra (SIEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Las Vegas, USA, March 15, 2022 (GLOBE NEWSWIRE) -- Breast Implants Market is Contemplated to Surge at a Tremendous CAGR of 7.00% by 2026, Asserts DelveInsight The increase in demand for Breast Implants is predominantly attributed to the growing prevalence of breast cancer among the population across the globe. In addition, the rising number of people demanding cosmetic surgeries mainly women to enhance their aesthetic appeal could also be a potential factor for increasing the Breast Implants market. Moreover, an increase in the number of breast augmentation surgeries and technological advancement in the product portfolio is expected to bolster the Breast Implant market during the forecasted period. DelveInsight''s Breast Implants Market Insights and Forecast report provides the current and forecast of Breast Implants, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Breast Implants Market scenario.

During the last session, Sientra Inc. (NASDAQ:SIEN)’s traded shares were 0.44 million, with the beta value of the company hitting 2.04. At the end of the trading day, the stock’s price was $2.31, reflecting an intraday loss of -3.75% or -$0.09. The 52-week high for the SIEN share is $9.14, that puts it down -295.67 … Boom Or Bust: Where Does Sientra Inc. (NASDAQ: SIEN) Stock Go From Here? Read More »

SANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Wednesday, March 23, 2022. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.

SANTA BARBARA, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the ar

Sientra Inc (SIEN) shares closed 0.6% lower than its previous 52 week low, giving the company a market cap of $187M. The stock is currently down 12.3% year-to-date, down 19.3% over the past 12 months, and down 62.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 11.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 293.6% The company's stock price performance over the past 12 months lags the peer average by -158.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.